Drug Type Gene editing |
Synonyms HSC-mediated diseases (Spotlight) |
Target |
Mechanism Hemoglobin HbA modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Spotlight Therapeutics, Inc.Startup |
Active Organization Spotlight Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemoglobinopathies | Preclinical | US | Spotlight Therapeutics, Inc.Startup | 22 Mar 2022 |